key: cord-1024667-po7cq9mq authors: Hellou, Mona Mustafa; Górska, Anna; Mazzaferri, Fulvia; Cremonini, Eleonora; Gentilotti, Elisa; De Nardo, Pasquale; Poran, Itamar; Leeflang, Mariska; Tacconelli, Evelina; Paul, Mical title: Nucleic-acid-amplification tests from respiratory samples for the diagnosis of coronavirus infections: systematic review and meta-analysis date: 2020-11-11 journal: Clin Microbiol Infect DOI: 10.1016/j.cmi.2020.11.002 sha: ff0e6b6b25114e42d827b9e08253ff6bbffd0b11 doc_id: 1024667 cord_uid: po7cq9mq BACKGROUND: Management and control of COVID-19 relies on reliable diagnostic testing. OBJECTIVES: To evaluate the diagnostic test accuracy (DTA) of nucleic acid-amplification tests (NAAT) for the diagnosis of coronavirus infections. DATA SOURCES: PubMed, Web of Science, the Cochrane Library, Embase, Open Grey and conference proceeding until May 2019. PubMed and medRxiv were updated on 31 August, 2020 for COVID-19. STUDY ELIGIBILITY: Studies reporting on agreement rates between different NAATs using clinical samples. PARTICIPANTS: Symptomatic patients with suspected upper or lower respiratory tract coronavirus infection. METHODS: The new NAAT was defined as the index test and the existing NAAT as reference standard. Data were extracted independently in duplicate. Risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. Confidence regions (CR) surrounding summary sensitivity/specificity pooled by bivariate meta-analysis are reported. Heterogeneity was assessed using meta-regression. RESULTS: Fifty-one studies were included; 22 including 10,181 persons before COVID-19 and 29 including 8,742 persons diagnosing SARS-CoV-2. The overall summary sensitivity was 89.1% (95% CR 84.0-92.7%), specificity 98.9% (95% CR 98.0-99.4%). Nearly all evaluated different PCRs both as index and reference standard. Real-time-RT PCR essays resulted in significantly higher sensitivity than other tests. Reference standards at high risk of bias possibly exaggerated specificity. The pooled sensitivity and specificity of studies evaluating SARS-COV-2 were 90.4% (95% CR 83.7-94.5%) and 98.1% (95% CR 95.9-99.2), respectively. SARS-COV-2 studies using lower respiratory tract samples, real-time RT-PCR and tests targeting the N, S or more than one gene showed higher sensitivity and RT-LAMP-based essays, especially when targeting only the RdRp gene, showed significantly lower sensitivity compared to other studies. CONCLUSIONS: Pooling all studies to date shows that about 10% of patients with coronavirus infections might be missed on average with PCR tests. Variables affecting sensitivity and specificity can be used for test selection and development. HCoV-229E and HCoV-NL63, and β-CoVs HCoV-HKU1 and HCoV-OC43 have low pathogenicity and cause mild respiratory symptoms similar to a common cold. The other two known as β-CoVs, SARS-CoV, MERS-CoV, and the current SARS-CoV-2 lead to severe and potentially fatal respiratory tract infections. The accuracy of tests to diagnose coronavirus infections is crucial for patient management and to control the pandemic. The SARS-CoV-2 real-time reversetranscriptase (RT)-PCR tests were developed under emergency conditions, based on analytic performance in the laboratory and not in real-life conditions. Several tests are currently available, most targeting the nucleocapsid protein (N) or spike (S) genes combining them with the envelope protein gene (E) or the RNA-dependent RNA polymerase gene (RdRP). The N gene provided lower analytical sensitivity (technical limit of detection of 8.3 copies) than the RdRP and E genes (3.6 and 3.9 copies, respectively). 1 The FDA approved the CDC test targeting the N gene under emergency conditions. 2 Since then, several nucleic-acid amplification tests (NAATs) have received FDA emergency use authorization (EUA). We aimed to summarize studies evaluating the diagnostic test accuracy (DTA) of The studies evaluated different PCRs as index tests; a single study described the development and testing of a CRISPR-based rapid assay based on Cas13a for SARS-CoV-2 detection. 26 Real time RT-PCR tests were used in 18/51 studies (Table 1) . RT-LAMP-based essays for detection of SARS-CoV-2 were assessed in 15 studies. All studies used a different PCR as reference standard, typically an approved commercial test that was in use in the laboratory performing the study or the reference laboratory. The reference standard was deemed optimal for coronavirus detection in seven studies using more than one PCR essay, serial testing, or next-generation sequencing alongside clinical presentation. 7, 13, 26, 38, 41, 45, 51 The specific species of the coronaviruses were reported in all but three of the studies before COVID-19 ( Table 1 ). The target gene/s were described only in 5/22 studies before COVID-19 16 Twenty-three studies were prospective (12/29 COVID-19 studies) and the remaining were retrospective or mixed, typically using stored samples for analysis (Table 1) 17 lack of crude numbers for both sensitivity and specificity (Table S1) 39 not diagnostic accuracy studies (Table S2) 3 studies included less than 20 patients (Table S3) 6 studies serology/ culture assessment (Table S4) 4 lack of access to full text version (Table S5) 12 lack of crude numbers for sensitivity/ specificity (Table S1) 8 not diagnostic accuracy studies (Table S2) 2 serology/ culture assessment (Table S4) Studies included in qualitative synthesis N = 51 Studies included in quantitative and synthesis (meta-analyses) N = 51 Articles assessing Coronavirus (May 2019-August 2020) N= 98 Diagnosing COVID-19: The Disease and Tools for Detection Prevention CfDCa. CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel 2020 QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews Meta-Analysis of Diagnostic Accuracy with mada2012 Performance evaluation of the point-of-care SAMBA II SARS-CoV-2 Test for detection of SARS-CoV-2 Multicenter Evaluation of the ePlex Respiratory Pathogen Panel for the Detection of Viral and Bacterial Respiratory Tract Pathogens in Nasopharyngeal Swabs Performance of Abbott ID Now COVIDin Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution Comparing Luminex NxTAG-Respiratory Pathogen Panel and RespiFinder-22 for multiplex detection of respiratory pathogens Detection of respiratory viruses using a multiplex real-time PCR assay in Germany Performance of a novel microarray multiplex PCR for the detection of 23 respiratory pathogens (SYMP-ARI study) Sensitivity, specificity and predictive values of molecular and serological tests for COVID-19. A longitudinal study in emergency room Rapid, sensitive and specific SARS coronavirus-2 detection: a multi-center comparison between standard qRT-PCR and CRISPR based DETECTR The Clinical Significance of FilmArray Respiratory Panel in Diagnosing Community-Acquired Pneumonia Development of a multiplex one step RT-PCR that detects eighteen respiratory viruses in clinical specimens and comparison with real time RT-PCR Comparison of fast-track diagnostics respiratory pathogens multiplex real-time RT-PCR assay with in-house singleplex assays for comprehensive detection of human respiratory viruses Evaluation of Four Commercial Multiplex Molecular Tests for the Diagnosis of Acute Respiratory Infections Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2 ddPCR: a more sensitive and accurate tool for SARS-CoV-2 detection in low viral load specimens Syndromic sample-toresult PCR testing for respiratory infections in adult patients Direct diagnostic testing of SARS-CoV-2 without the need for prior RNA extraction Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: In-field learnings from a clinical microbiology laboratory Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens Rethinking Covid-19 Test Sensitivity -A Strategy for Containment. The New England journal of medicine Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility -King County Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR